Finding a new use for an approved therapy is always welcome news. Finding a use that improves outcomes for a condition where ...

Three persistent barriers are preventing patients with obstructive sleep apnea (OSA) from receiving timely diagnosis and ...

Sunil Sharma, MD, discusses the consequences of not diagnosing patients with sleep-disordered breathing during hospital ...

Baseline QOL is an independent prognostic factor for survival in AML, with global QOL carrying the largest HR, according to ...

Prolonged referral-to-testing workflows motivate using wearable-derived respiratory surrogates to triage suspected ...

Pooled TETON‑1/2 trials met the primary endpoint, demonstrating significantly less 52‑week FVC loss with inhaled treprostinil than placebo. Efficacy signals extended to secondary outcomes, reducing ...

Behavioral health utilization rose 62.6% since 2018 and dominates telehealth; timely outpatient linkage reduces behavioral health ED visits and admissions, yielding about $27.63 PMPM total medical ...

After decades of neglect, malnutrition-related diabetes, or type 5, is finally getting the research, recognition, and ...

This analysis compared health care resource utilization and costs for Medicaid patients with serious mental illness between ...

Specialty pharmacies reduce administrative burden and total cost of care as advanced therapies move to community sites, Fran ...

AJMC: 64% of patients who responded to pCR skipped traditional chemotherapy entirely, and 97% avoided anthracyclines. For patients and oncologists, what does that mean in practice, and how do you ...

Permanent rulemaking would replace IPAY 2026–2028 guidance, enabling predictable annual negotiations of up to 20 drugs and defined manufacturer agreement and renegotiation requirements. Formularies ...